Dabur India Limited — FDA Class II (D-0639-2026)

Dabur India Limited is recalling 4,738 tubes of a drug due to CGMP (current good manufacturing practices) deviations. The recall is classified as a Class II recall, indicating a temporary health risk. The recall affects products distributed in the U.S.

• •Dabur India Limited is recalling 4,738 tubes of a drug.
• •The recall is due to CGMP deviations observed during inspections.
• •This is classified as a Class II recall.
• •Consumers should check their medicine cabinets for the recalled product.

Consumers who purchased the recalled tubes should stop using them immediately. The recall affects 4,738 tubes due to manufacturing deficiencies that could pose health risks.